Topics include Biden's debate performance, Trump's sentencing delay, FDA approval of Alzheimer's drug, wildfire evacuations, COVID cases, frog saunas for disease, and more.
Legal team aims to use immunity ruling to challenge evidence in Trump's conviction.
FDA approval of Alzheimer's drug Casunla raises hopes for cognitive decline treatment.
Deep dives
Trump's Sentencing Delayed Due to New Legal Arguments
Trump's sentencing in the New York hush money case was postponed following a Supreme Court ruling that presidents are immune from prosecution for official actions during their term. His legal team aims to leverage this ruling to challenge the evidence in his recent conviction. Despite concerns, the Biden campaign continues unaffected by calls for Biden to step aside.
FDA Approves New Alzheimer's Drug Despite Previous Safety Concerns
The FDA approved Casunla, a drug for early symptomatic Alzheimer's after addressing initial concerns about safety. The drug, expected to slow cognitive decline, will be available in northern India. Elsewhere, an aggressive wildfire in California prompted evacuations amid extreme heat, and a study in Australia found that tiny saunas could help frogs combat a deadly fungal infection.